OM1 Publications

» Rheumatology
» Mental Health & Neuroscience
» Multiple Sclerosis
» Cardiometabolic

» Dermatology
» Respiratory/ENT
» Gastroenterology
» Oncology

» NASH
» Rare Diseases
» Books
» Other

Rheumatology

  1. Poster (1st place winner): Alves P, Gerber J, Spencer A, Bandaria J, Leavy M, Weiss S, Curhan G, Marci C, Paulus J, Boussios C. Lessons Learned from the Development of Machine Learning Models to Estimate Validated Measures of Disease Activity and Symptom Severity Using Real-World Data for Four Chronic Conditions. ICPE, August 23-27, 2023.
  2. Poster: Alves P, Spencer A, Bandaria J, Leavy M, Weiss S, Curhan G, Marci C, Boussios C. Machine Learning Models to Estimate Disease Activity Measures in Real-World Data Sources: Lessons Learned from Four Autoimmune Diseases. ISPOR Annual, May 2023, Boston, MA.
  3. Poster: Su Z, Stevens L, Brecht T, Weiss S. Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis Patients.  ACR conference, November 12-14, 2022, Philadelphia, PA, USA.
  4. Poster: Su Z, Stevens L, Brecht T, Weiss S. Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Rheumatoid Arthritis Patients. ACR conference, November 12-14, 2022, Philadelphia, PA, USA.
  5. Poster: Starzyk K, Kumparatana P, Meng R, Probst J. Characterization of Non-radiographic Axial Spondyloarthritis Patients and the Burden of Disease in Routine Clinical Practice. ACR Convergence, November 12-14, 2022.
  6. Poster: Stevens L, Mulder K, Su Z, Kumparatana P, Weiss S. Effect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical Practice. ACR Convergence, November 12-14, 2022.
  7. Poster: Starzyk K, Brault J, Curhan G. A Cross-Sectional Study of Rheumatoid Arthritis (RA) Diagnoses in Patients with Systemic Lupus Erythematosus (SLE). ACR Convergence 2021, November 6, 2021.
  8. Peer-Reviewed Journal: Spencer AK, Bandaria J, Leavy MB, Gliklich B, Su Z, Curhan G, Boussios C. Validation of a Machine Learning Approach to Estimate Clinical Disease Activity Index Scores for Rheumatoid Arthritis. RMD Open (Journal of Rheumatic and Musculoskeletal disorders), November 2021;7:e001781. DOI:10.1136/rmdopen-2021-001781.
  9. Poster Collaboration: Icten Z, Starzyk K, Friedman M, Menzin J. Characterizing Non-Response to Methotrexate Monotherapy Among Rheumatoid Arthritis Patients in a Large Real-World Longitudinal Cohort. Panalgo & OM1, EULAR 2022, June 1-4, 2022.
  10. Poster Collaboration: Bergman M, Tundia N, Bryant A, Topuria I, Brecht T, Ali M, Gibofsky A. Patient Characteristics and Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: The OM1 RA Registry. Abbvie & OM1, EULAR Conference, June 2021.
  11. Poster Collaboration: Icten Z, Starzyk K, Friedman M, Menzin J. Prediction of Non-Response to First-Line Methotrexate Treatment in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning. Panalgo & OM1 collaboration, ISPOR 2022, May 15-18, 2022.
  12. Peer-Reviewed Journal: Alves P, Bandaria J, Leavy MB, Gliklich R, Boussios C, Su Z, Curhan G. Validation of a Machine Learning Approach to Estimate Systemic Lupus Erythematosus Disease Activity Index Score Categories and Application in a Real-World Dataset. RMD Open (Journal of Rheumatic and Musculoskeletal disorders), 2021;7:e001586. DOI: 10.1136/rmdopen-2021-001586.
  13. Peer-Reviewed Journal: Jayakumar P, Moore MG, Furlough KA, Uhler LM, Andrawis JP, Koenig KM, Aksan N, Rathouz PJ, Bozic KJ. Comparison of an Artificial Intelligence–Enabled Patient Decision Aid vs Educational Material on Decision Quality, Shared Decision-Making, Patient Experience, and Functional Outcomes in Adults with Knee Osteoarthritis: A Randomized Clinical Trial. JAMA Network Open. 2021; 4(2): e2037107. DOI:10.1001/jamanetworkopen.2020.37107
  14. Peer-Reviewed Journal: Harbaugh RE, Devin C, Leavy MB, Ghogawala Z, Archer KR, Bydon M, Goertz C, Dinstein D, Nerenz DR, Eakin GS, Lavelle W, Shaffer WO, Arnold PM, Washabaugh CH, Gliklich RE. Harmonized Outcome Measures for Use in Degenerative Lumbar Spondylolisthesis Patient Registries and Clinical Practice. Journal of Neurosurgery: Spine. 2021;1-9: DOI: 10.3171/2020.9.SPINE20437.
  15. Peer-Reviewed Journal: Imel E, Starzyk K, Gliklich R, et al. Characterizing Patients Initiating Abaloparatide, Teriparatide, or Denosumab in a Real-World Setting: a US Linked Claims and EMR Database Analysis. Osteoporosis International. 2020; 31: 2413–2424. DOI:10.1007/s00198-020-05388-y.
  16. Poster: Starzyk KA, Milberg K, Deshpande A, Swenson A, Curhan G. An Evaluation of Real-World Use of Biologics in Rare Systemic Vasculitides During Routine Clinical Care in the US. Virtual ACR Convergence, November 2020.
  17. Poster: Cavanaugh C, Donadio G, Starzyk K, Behling M, Curhan G, Gliklich R. Assessing Comorbid Inflammatory Arthritis Conditions and Swollen to Tender Joint Count Ratios in a Real-World Systemic Lupus Erythematosus Cohort. ICPE All Access, Sept 2020.
  18. Poster: Cavanaugh C, Donadio G, Starzyk K, Behling M, Curhan G, Gliklich R. Joint Involvement and Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Calculation of Swollen to Tender Joint Count Ratio in a Real-World Cohort in the U.S. EULAR E-Congress, June 2020.
  19. Abstract: Behling M, Cavanaugh C, Mortimer K, Cerf S, Starzyk K, Gliklich R. Predictors of Improvement in Tender Joint Counts Among Patients with Systemic Lupus Erythematosus in A Large, Representative US-Based Real-World Registry Cohort. ISPOR Annual Conference. Orlando, FL, May 2020.
  20. Abstract: Starzyk K, Brecht T, Behling M, Gliklich R, Curhan G. Characteristics and Disease Management in a Large Real-World Lupus Nephritis Cohort in the US. ISPOR Annual Conference. Orlando, FL, May 2020.
  21. Poster: Donadio G, Swenson A, Starzyk K, Gliklich R. Patient Characteristics and Management Of Juvenile Idiopathic Arthritis (JIA) In a Large, Representative Real-World Cohort. ISPOR EU Annual Conference. Copenhagen, Denmark, November 2019.
  22. Poster: Mortimer K, Starzyk K, Brecht T, Cerf S, Ballentine P, Gliklich R. Availability of Disease Activity Measures from Systemic Lupus Erythematosus Patients in a Large, Representative US-Based Real World Registry Cohort. ICPE Annual Conference. Philadelphia, PA. August 2019.
  23. Poster: Mortimer K, Swenson A, Brecht T, Struebel B, Cerf S, Lafontant A, Gliklich R. Improvements in Disease Activity Scores Associated with bDMARD use by Rheumatoid Arthritis Patients in a Large US-Based Real World Cohort. ICPE Annual Conference. Philadelphia, PA. August 2019.
  24. Poster: Mortimer K, Starzyk K, Brecht T, Cerf S, Ballentine P, Gliklich R. Patient Characteristics and Current Management of Systemic Lupus Erythematosus Patients in a Large, Representative US-Based Real World Cohort. FOCIS Annual Conference. Boston, MA. June 2019.
  25. Poster: Swenson A, Starzyk K, Mortimer K, Brecht T, Li F, Strubel B, Gliklich R. Age and Gender Differences in Comorbidities among Patients with Rheumatoid Arthritis in a Large US-Based Real World Cohort. AMCP Annual Conference. San Diego, CA. March 2019.
  26. Poster: Su Z, Brecht T, Gliklich R, Menon V. Treatment Patterns in Large Vessel Arteritis (Giant Cell Arteritis and Temporal Arteritis): Findings from a Large Contemporaneous Real-World Cohort in the US. ACR/ARHP Annual Meeting. San Diego, CA. November 4-8, 2017.
  27. Poster: Gliklich R, Su Z, Brecht T, Menon V. Initiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Large Contemporaneous Real World Cohort. ACR/ARHP Annual Meeting. San Diego, CA. November 4-8, 2017.
  28. Abstract: Gliklich R, Su Z, Brecht T, Menon V. Comparison of Improvements in Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real World Cohort. ACR/ARHP Annual Meeting. San Diego, CA. November 4-8, 2017.
  29. Poster: Su Z, Brecht T, Gliklich R, Menon V, Initiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Next Generation Registry, ISPOR Annual Conference. Boston, MA. May 2017.
  30. Poster: Su Z, Brecht T, Menon V, Gliklich R, Solomon DH, Patient Reported Outcomes and Changes in DMARD Therapy for Rheumatoid Arthritis in Routine Clinical Practice, ISPOR Annual Conference, Boston, MA. May 20-24, 2017.

Back to top

 

Mental Health & Neuroscience

  1. Poster: Semeniuta D, Marci CD, Bandaria J, Zabinski JW, Paulus JK, Boussios C. Identification of Treatment Resistant Major Depressive Disorder using a Machine Learning Algorithm.  ICPE, August 2023.
  2. Poster: Boussios C, Spencer A, Alves P, Leavy M, Curhan G, Marci CD. Use of Medical Language Processing in Real-World Data to Understand Antidepressant Side Effects and Improve Research in Mental Health.  American Psychiatric Association Annual Meeting, May 2023.
  3. Poster: Gerber J, Marci CD, Leavy M, Alves P, Boussios C. Development of a Machine Learning Model for Estimating PHQ-9 Scores Using Clinical Notes from Real-World Data Sources.  American Society of Clinical Psychopharmacology, May 2023.
  4. Poster: Nelson J, Hoffman V, Marci CD, Paulus JK. The Association Between Credit Risk Score and Major Depressive Disorder Burden Using a Machine Learning Estimation of the PHQ-9 in a Real-World Cohort.  ICPE, August 23-27, 2023.
  5. Peer-Reviewed Journal: Doane M, Bessonova L, Friedler H, Mortimer K, Cheng H, Brecht T, O’Sullivan A, Cummings H, McDonnell D, Meyer J. Weight Gain and Comorbidities Associated With Oral Second-Generation Antipsychotics: Analysis of Real-World Data for Patients With Bipolar I Disorder or Schizophrenia.  BMC Psychiatry. 2022; 22(114). DOI: 10.1186/s12888-022-03758-w.
  6. Peer-Reviewed Journal: Gliklich RE, Leavy MB, Cosgrove L, Simon GE, Gaynes BN, Peterson LE, Olin B, Cole C, DePaulo JR Jr, Wang P, Crowe CM, Cusin C, Nix M, Berliner E, Trivedi MH. Harmonized Outcome Measures for Use in Depression Patient Registries and Clinical Practice. Annals of Internal Medicine. 2020;172(12): 803-809. DOI:10.7326/M19-3818
  7. Poster: Paulus J, Severtson G, Qian X, Kumparatana P, Hoffman V, Su Z, Marci CD. The Association Between Race, Social Determinants of Health, and Treatment for Major Depressive Disorder (MDD) in a Real-World Cohort. ICPE, August 24-28, 2022.
  8. Poster: Hoffman V, Cheng H, Brecht T, Paulus J,  Marci CD. Changes in Weight Across the Life Span in Patients with Bipolar Disorder I Treated with Second Generation Antipsychotics. ICPE, August 24-28, 2022.
  9. Poster: Palmon N, Alves P, Momen S, Leavy M, Curhan G, Boussios C, Jones C, Gliklich R. Use of a Natural Language Processing-Based Approach to Extract Depression Symptom Severity and Suicide Ideation from Clinical Notes to Support Depression Research, ICPE 2021 Virtual Meeting, August 2021.
  10. Poster collaboration: Doane M, Bessonova L, Mortimer K, Cheng H, Donadio G, Brecht T, O’Sullivan A, Cummings H, McDonnell D, Meyer J. Weight Gain and Treatment Interruptions With Second-Generation Oral Antipsychotics: Analysis of Real-World Data Among Patients With Schizophrenia or Bipolar I Disorder. Psych NEI November 2020.
  11. Poster: Leavy, M, Clarke D, Gibson D, Hajjar S, Berliner E. Evaluating the Feasibility of Capturing a Core Set of Harmonized Depression Outcome Measures in Primary Care and Mental Health Patient Registries. SGIM Conference, June 2020.
  12. Poster: Mortimer K, Behling M, Swenson A, Li F, Brecht T, Strubel B, Cerf S, Lafontant A, Gliklich R. Depression and Patient Outcomes Among Rheumatoid Arthritis Patients in a Large US-Based Real World Cohort. ISPOR Annual Conference. New Orleans, LA. May 2019.
  13. Poster: Su Z, Brecht T, Lafontant A, Boussios C, O’Donovan F, Kekeh C, Starzyk K, Gliklich R, Menon V. Patient & Provider Characteristics Associated with PHQ-9 Administration and Outcomes Assessment in Routine Clinical Practice: Findings from the OM1 Intelligent Data Cloud. ISPOR Annual Conference. Baltimore, MD. May 2018.

Back to top

 

Multiple Sclerosis

  1. Poster: Alves P, Bryant Z, Leavy M, Curhan G, Boussios C, Marci CD. Characterizing Disease Progression in Multiple Sclerosis Subtypes Using RWD: Feasibility of Applying a Machine Learning Model to Address Missing Data. ICPE, August 23-27, 2023.
  2. Peer-Reviewed Journal: Alves P, Green E, Leavy M, Friedler H, Curhan G, Marci C, Boussios C. Validation of a Machine Learning Approach to Estimate Expanded Disability Status Scale Scores for Multiple Sclerosis.  Multiple Sclerosis Journal – Experimental, Translational and Clinical. April 2022. DOI:10.1177/20552173221108635.
  3. Poster: Brecht T, Starzyk K, Mulder K, Paulus, J, Curhan G, Friedler H, Su Z. Assessing the Expanded Disability Status Scale in Secondary Progressive Multiple Sclerosis Patients Treated with Disease Modifying Therapies within a Large, Representative Real World Multiple Sclerosis Registry. ACTRIMS, Feb 24-26, 2022.
  4. Poster: Friedler H, Mulder K, Cerf S, Marks S, Topuria I, Su Z, Curhan G, Paulus J, Gliklich R.  Assessing Comorbid Behavioral Health Conditions, Healthcare Resource Utilization, and Medication Use in Patients Seeking Mental Health Care within a Large, Representative Real-World Multiple Sclerosis Registry. CNS Summit 2021, November 7-10, 2021.
  5. Peer-Reviewed Journal: Alexander JK, Ariely R, Wu Y, Hulbert E, Bryant A, Su Z, Vardi M, Kasturi J. Real-World Adherence, Discontinuation, and Switching among Patients with Multiple Sclerosis Initiating Generic Glatiramer Acetate from Two Large Real-world Databases in the United States. Current Medical Research and Opinion. 2021; 37(8). DOI: 10.1080/03007995.2021.1929135
  6. Poster: Topuria I, Cavanaugh C, Donadio G, Starzyk K, Gliklich R. Comparison of Symptoms, Treatments, and Healthcare Resource Utilization in Patients with Multiple Sclerosis by Sex in a Real-World Cohort in the U.S. ICPE All Access, September 2020.
  7. Poster: Coste, M., Fenton, MC., Choudhry, Z., Ozog, M., Hashemi, L., Poole, E., Behling, M., Mortimer, K., Aschenbach, B., Guikema, B. A Real-World Retrospective Analysis of Outcomes in Multiple Sclerosis Patients Who Transitioned to Alemtuzumab After Rituximab or Ocrelizumab. American Academy of Neurology Annual Meeting, April 2020.
  8. Poster collaboration: Alexander J, Kasturi J, Melamed-Gal S, Ariely R, Carroll B, Su Z, Bryant A, Schobel V. Treatment Patterns and Reasons for Switching among US Patients with Multiple Sclerosis Taking the Glatiramer Acetate Class of Products. Poster, ACTRIMS Forum 2020, West Palm Beach, FL, February 2020.
  9. Poster: Behling M, Bryant A, Brecht T, Cerf S, Gliklich R, Su Z. Predicting Relapse Episodes in Patients with Multiple Sclerosis Treated with Disease Modifying Therapies in a Large Representative US-Based Real World Cohort. ICPE Annual Conference. Philadelphia, PA. August 2019.
  10. Poster: Allison Bryant, Michael Behling, Shannon Cerf, Richard Gliklich. Revisiting MS Prevalence in the 21st Century: Exploration Based on a Large Representative US-Based Real-World Cohort. ICPE Annual Conference. Philadelphia, PA. August 2019.
  11. Poster collaboration: Alexander J, Kasturi J, Melamed-Gal S, Ariely R, Vardi M, Su Z, Brecht T, Bryant A. Real-World Switching Patterns Among US Generic Glatiramer Acetate Multiple Sclerosis Patients. Poster, American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, May 2019.

Back to top

 

Cardiometabolic

  1. Poster: Probst J, Jung Y, Su Z, Curhan G, Paulus J. The Association Between Social Determinants of Health and 1-Year Survival Among Patients with Heart Failure in a Real-World Cohort. ICPE, August 23-37, 2023.
  2. Poster: Paulus J, Severtson G, Atreja N, Hines D, Jiang J, Gao C, Cheng D, Hagan M, Secemsky E. Defining Provider Prescribing Preference as an Instrumental Variable: A Case Study of NOACs in Stroke Prevention. ICPE, August 23-37, 2023.
  3. Poster: Bryant A, Brecht T, Behling M, Starzyk K, Curhan G. Characteristics of Asymptomatic Heart Failure Patients with Reduced Ejection Fraction in a Large US-Based Real-World Cohort. Poster, 37th Annual International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 2021.
  4. Peer-Reviewed Journal: Calkins H, Gliklich RE, Leavy MB, Piccini JP, Hsu JC, Mohanty S, Lewis W, Nazarian S, Turakhia MP. Harmonized Outcome Measures for Use in Atrial Fibrillation Patient Registries and Clinical Practice. Endorsed by the Heart Rhythm Society Board of Trustees. Heart Rhythm. 2019;16(1): e3-e16. PMID: 30449519. DOI: 10.1016/j.hrthm.2018.09.021.
  5. White paper: Gliklich RE, Leavy MB, Li F. Standardized Library of Atrial Fibrillation Outcome Measures. Research White Paper. (Prepared by L&M Policy Research, LLC under Contract No. 290-2014-00004-C.) AHRQ Publication No. 18(19)-EHC026-EF. Rockville, MD: Agency for Healthcare Research and Quality; November 2018.
  6. Poster: Piccini JP, Calkins H, Leavy M, Hsu J, Lewis WR, Nazarian S, Turakhia M, Mohanty S, Berliner E, Gliklich R. Variation in Outcome Measures in Atrial Fibrillation Registries and the Need for Harmonization. Heart Rhythm Scientific Sessions. Boston, MA. May 9-12, 2018.
  7. Peer-Reviewed Journal: Gliklich R, Donadio G, Brecht T, O’Donovan F, Boussios C, Menon V, Su Z. A Highly Predictive Machine Learning Model to Identify Hospitalized Patients at Risk for 30-day Readmission or Mortality. Journal of the American College of Cardiology. 2018 Mar, 71 (11_Supplement) A1734. DOI: 10.1016/S0735-1097(18)32275-7.
  8. Poster: O’Donovan F, Brecht T, Kekeh C, Su Z, Boussios C, Menon V, Gliklich R, Fonarow G, Geffen D. Machine Learning Generated Risk Model to Predict Unplanned Hospital Admission in Heart Failure. AHA Scientific Sessions. Anaheim, CA. November 11-15, 2017.
  9. Poster: Su Z, Brecht T, Gliklich R, Menon V. A Simple Predictive Score for Pre-Admission Identification of Risk of 30-Day Hospital Readmission or Death in Heart Failure, Journal of the American College of Cardiology. 2017; 69 (11): Supplement.
  10. Presentation: Berliner E, Gliklich R, Wallace P, Chin J, Slattery L. Unleashing the Power of Patient Registries through Harmonized Outcomes: An Early Test of the Outcomes Measure Framework (OMF) in Atrial Fibrillation. Challenge Workshop, Academy Health Concordium Conference. Washington DC. September 12, 2016.

Back to top

 

Dermatology

  1. Poster (Collaboration with Amgen): Cavanaugh C, Orroth K, Kumparatana P, Klyachkin Y, Colgan S, Deignan C, Cordey M, Mehta N; A Real World Analysis of Apremilast and Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis, Including Impact on Weight Loss by Diabetic Status. Presented at European Academy of Dermatology and Venereology, Berlin, Germany; October 11-14, 2023.
  2. Poster (Collaboration with GSK): Symons J,  Breeze J, Severtson S, Weiss S, Karsanji U, Nickolls S, Patel D. Treatment Supplementation Following Dupilumab Initiation in Real-World Patients With Atopic Dermatitis in the U.S. Clinical Dermatology Conference, October 19–22, 2023, Las Vegas, NV.
  3. Poster: Starzyk K, Elyze M, Weiss S. Patient Characteristics and Social Determinants of Health in a Large Real-World Cohort of Vitiligo Patients in the U.S. ISPOR Annual, May 2023 Boston, MA.
  4. Poster: Starzyk K, Elyze M, Weiss S. Real-World Characterization and Management of Alopecia Areata Patients in the U.S. ISPOR Annual, May 2023 Boston, MA.
  5. Poster: Mulder K, Su Z, Stevens L, Kumparatana P, Weiss S. Patient-Reported Outcomes and Changes in DMARD Therapy Among Psoriatic Arthritis Patients Treated in Routine Clinical Practice. AAD Annual Meeting, March 2023, New Orleans LA.
  6. Poster: Stevens L, Meng R, Kumparatana P, Weiss S. Comparison of Improvements in Psoriatic Arthritis Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real-World Cohort. AAD March, 2023.
  7. Poster: Elyze M, Stevens L, Weiss S. Management of HS by Dermatologists and Rheumatologists: Findings from a Large Contemporaneous Real-World Longitudinal Database. AAD Annual Meeting, March 2023, New Orleans LA.
  8. Poster: Stevens L, Kumparatana P, Elyze M, Clemens R, Weiss S. Characterization of Patients with Co-morbid Dermatological and Mental Health Conditions. AAD Annual Meeting, March 2023, New Orleans LA.
  9. Poster: Swenson A, Kumparatana P, Friedler H, Starzyk K, Paulus J. Real-World Use of Biologics and Prescription Topical Medications in Pediatric Psoriasis in a Large Dermatology Network in the U.S. ISPOR 2022, May 15-18, 2022.

Back to top

 

Respiratory/ENT

  1. Peer-Reviewed Journal & Collaboration with AAO: Hoffman V, Mulder K, Topuria I, Gawlicka A, Kallman J. Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study. Current Medical Research and Opinion, April 2023, DOI:10.1080/03007995.2023.2194776
  2. Peer-Reviewed Journal: Hoffman V, Mortimer K, Mulder K, Topuria I, Gliklich R, Kallman J. Real-World Evidence Analysis of the Impact of Steroid-Eluting Implants on Healthcare Resource Use Among Chronic Rhinosinusitis Patients Undergoing Sinus Surgery, Current Medical Research and Opinion, January 2022, DOI: 10.1080/03007995.2021.2022874.
  3. Peer-Reviewed Journal: Gliklich R, Castro M, Leavy MB, Press VG, Barochia A, Carroll CL, Harris J, Rittner SS, Freishtat R, Panettieri RA Jr, Mosnaim GS. Harmonized Outcome Measures for Use in Asthma Patient Registries and Clinical Practice. The Journal of Allergy and Clinical Immunology. 2019; pii: S0091-6749(19)30342-2. DOI: 10.1016/j.jaci.2019.02.025.
  4. White paper: Gliklich RE, Leavy MB, Li F. Standardized Library of Asthma Outcome Measures. Research White Paper. (Prepared by L&M Policy Research, LLC under Contract No. 290-2014-00004-C.) AHRQ Publication No. 19-EHC004-EF. Rockville, MD: Agency for Healthcare Research and Quality; April 2019.

Back to top

 

Gastroenterology

  1. Poster: Swenson A, Womack K, Quinn M, Curhan G. Method To Derive A Crohn’s Disease Activity Index From Electronic Health Records Data. Crohn’s and Colitis Congress. January 19, 2023.
  2. Poster: Swenson A, Womack K, Quinn M, Curhan G. Method to Derive a Modified Mayo Score from Electronic Health Records Data. Crohn’s and Colitis Congress. January 19, 2023.

Back to top

 

Oncology

  1. Poster Collaboration: Jung Y, Stevens L, Davies A, Glenister J, Pohlman S, Paulus J. Collaboration between Hologic and OM1. Representation of patients of minority race and ethnicity in real-world databases and tumor registries of patients with breast cancer. ICPE, August 23-27, 2023.
  2. Peer-Reviewed Journal: Emily F. Conant , Melinda M. Talley, Chirag R. Parghi, Bryant C. Sheh, Su-Ying Liang, Scott Pohlman, Amey Rane, Yoojin Jung, Lauren A. S. Stevens, Jessica K. Paulus, Nila Alsheik. Mammographic Screening in Routine Practice: Multisite Study of Digital Breast Tomosynthesis and Digital Mammography Screenings. Radiology Society of North America. DOI: 10.1148/radiol.221571.
  3. Peer-Reviewed Journal: Edelman M, Raymond D, Owen D, Leavy M, Chansky K, Yennu S, Fernandez F, Presley C, Biswas T, Quinn G, Schabath M, Sheffler-Collins S, Chu L, and Gliklich R. Harmonized Outcome Measures for Use in Non–Small Cell Lung Cancer Patient Registries and Clinical Practice. JNCCN, Official Journal of the National Comprehensive Cancer Network, August 2021; DOI: 10.6004/jnccn.2021.7021.
  4. Peer-Reviewed Journal: Alsheik N, Blount L, Qiong Q, Talley M, Pohlman S, Troeger K, Abbey G, Mango ML, Pollack E, Chong A, Donadio G, Behling M, Mortimer K, Conant E. Outcomes by Race in Breast Cancer Screening With Digital Breast Tomosynthesis Versus Digital Mammography. Journal of the American College of Radiology (JACR). 2021 Jul;18(7):906-918. DOI: 10.1016/j.jacr.2020.12.033.
  5. Peer-Reviewed Journal: Leavy MB, Starzyk K, Myers E, Curhan G, Gliklich R. Using Real-World Evidence to Support a Changing Paradigm for Cancer Screening: A Commentary. Pharmacoepidemiology Drug Saf. 2020;1–4. DOI: 10.1002/pds.5104.
  6. Presentation: Conant EF, Mortimer K, Friedler H, Behling M, Donadio G, Hitchcock C, Pohlman S, Sardiña A, Talley M, Alsheik N, Effect of Breast Cancer Screening Modality Order on Recall, Cancer Detection Rates, and Positive Predictive Value 1 for Women with Multiple Screening Exams. Virtual RSNA 2020. Philadelphia, PA, October 2020.
  7. Peer-Reviewed Journal: Alsheik NH, Dabbous F, Pohlman SK, Troeger KM, Gliklich RE, Donadio GM, Su Z, Menon V, Conant EF. Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System. Academic Radiology. 2019 May;26(5):597-605. DOI: 10.1016/j.acra.2018.05.026.
  8. Poster: Alsheik N, Su Z, Lafontant A, Donadio G, Troeger K, Pohlman S, Talley M, Menon V, Conant E. Disparities in Accessing Screening Mammography: Opportunities for Improving Diagnostic Outcomes. National Comprehensive Cancer Network Annual Conference, Orlando. March 21–23, 2019.
  9. Poster: Dabbous F, Su Z, Donadio G, Dolan J, Menon V, Alsheik N; Towards Personalized Breast Imaging Pathways: Initial Findings from a Learning Health System. ACOG  Annual Conference, March 2018.
  10. Poster: Alsheik N, Dabbous F, Donadio G, Su Z, Gliklich R, Pohlman S, Mortimer K, Menon V, Conant E. Impact of Population Characteristic on Recall Rates: Initial Finding from a Learning Health System. NCCN Annual Conference, March 2018

Back to top

 

NASH

  1. Friedler HS, Mortimer KM, Cheng, H, Topuria I, Cerf S, Curhan, G, Gliklich R, Su Z. Predicting Disease Progression in Non-Alcoholic Steatohepatitis (NASH) Patients with Early Stage Fibrosis Within a Large, Representative Real-World Database of US Patients. DDW Annual Conference, April 2021.
  2. Poster: Bandaria J, Boussios C, Donadio G, Starzyk K, Gliklich R. Identifying Progressing Patients in an Artificial Intelligence (AI) Based Cohort of Nonalcoholic Steatohepatitis (NASH). ISPOR EU Annual Conference. Copenhagen, Denmark, November 2019.
  3. Poster: Bandaria J, Boussios C, Donadio G, Li F, Mortimer K, Gliklich R, Starzyk K. Findings From a Non-Alcoholic Steatohepatitis (NASH) Cohort Developed via Artificial Intelligence in a Large Representative Population in the U.S. DDW Annual Conference. San Diego CA. May 2019.

Back to top

 

Rare Diseases

  1. Peer-Reviewed Journal: Jefferies JJ, Spencer AK, Lau HA, Nelson MW, Giuliano JD, Zabinski JW, Boussios C, Curhan G, Gliklich RE, Warnock DG. A New Approach to Identifying Patients with Elevated Risk for Fabry Disease Using a Machine Learning Algorithm. BMC: Orphanet Journal of Rare Diseases (OJRD). 2021; 16 (518). DOI:10.1186/s13023-021-02150-3.

Back to top

 

Books

  1. Gliklich RE, Leavy MB, Dreyer NA (sr eds). Registries for Evaluating Patient Outcomes: A User’s Guide. 4th ed. (Prepared by L&M Policy Research, LLC, under Contract No. 290-2014-00004-C with partners OM1 and IQVIA) AHRQ Publication No. 19(20)- EHC020. Rockville, MD: Agency for Healthcare Research and Quality; September 2020.
  2. Gliklich R, Dreyer N, Leavy M, Christian J (eds). 21st Century Patient Registries. Ebook addendum to Registries for Evaluating Patient Outcomes: A User’s Guide, Third Edition. (Prepared by L&M Policy Research, LLC under Contract No. 290-2014-00004-C.) AHRQ Publication No. 17(18)-EHC013-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2018.
  3. Greenberg B, Christian J, Henry LM, Leavy MB, Moore H. Biorepositories. White Paper, addendum to Registries for Evaluating Patient Outcomes: A User’s Guide, Third Edition. (Prepared by L&M Policy Research, LLC, under Contract No. 290-2014-00004-C.) AHRQ Publication No. 17(18)-EHC014-EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2018. www.effectivehealthcare.ahrq.gov.
  4. Mack C, Su Z, Weistreich D. Managing Missing Patient Data in Patient Registries. White Paper, addendum to Registries for Evaluating Patient Outcomes: A User’s Guide, Third Edition. (Prepared by L&M Policy Research, LLC, under Contract No. 290-2014-00004-C.) AHRQ Publication No. 17(18)-EHC015-EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2018. www.effectivehealthcare.ahrq.gov.
  5. Leavy MB. Multinational Registries: Challenges and Opportunities. White Paper, addendum to Registries for Evaluating Patient Outcomes: A User’s Guide, Third Edition. (Prepared by L&M Policy Research, LLC, under Contract No. 290-2014-00004-C.) AHRQ Publication No. 17(18)-EHC016EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2018. www.effectivehealthcare.ahrq.gov.

Back to top

 

Other

  1. Peer-Reviewed Journal: Gliklich RE, Leavy MB. Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence. Therapeutic Innovation & Regulatory Science. 2019;0(0). DOI:10.1177/2168479019837520. PMID: 30917687.
  2. Poster: Paulus J, Cavanaugh C, Topuria I, Su Z. Application of E-Value Analysis to Gauge Unmeasured Confounding in Real-World Data (RWD) Studies. CNS Summit 2021, November 7-10, 2021.
  3. Report: Leavy MB, Schur C, Kassamali FQ, Johnson ME, Sabharwal R, Wallace P, Gliklich RE. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned. Final Report. (Prepared by L&M Policy Research, LLC under Contract No. 290-2014-00004-C) AHRQ Publication No. 19-EHC008-EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2019.
  4. Poster: Bryant A, Brecht T, Su Z, Gliklich R, Menon V. Impact of New Guidelines for High Blood Pressure: Findings from the OM1 Intelligent Data Cloud. ISPOR Annual Conference. Baltimore, MD. May 2018.
  5. Report: Gliklich RE, Bibeau K, Eisenberg F, Hanna J, Leavy MB, Campion D, Christian JB. Registry of Patient Registries Outcome Measures Framework: Information Model Report. Methods Research Report. Methods Research Report. (Prepared by L&M Policy Research, LLC, under Contract No. 290-2014-00004-C.) AHRQ Publication No. 17(18)-EHC012-EF. Rockville, MD: Agency for Healthcare Research and Quality; February 2018. www.effectivehealthcare.ahrq.gov.
  6. Poster: Gliklich R, Leavy M, Berliner E. Testing the Robustness of the Outcome Measures Framework. ICPE Annual Conference. Montreal, Canada. August 26-30, 2017
  7. Berliner E, Gliklich R, Franklin P. Measuring What Matters: Is Standardized Outcome Measurement Necessary to Support Value-Based Care? Issues panels. ISPOR Annual Conference, Boston, MA, May 20-24, 2017.
  8. Berliner E, Gliklich R, Franklin P, Wallace P. Tearing Down the Tower of Babel in Outcome Measures. Issue Panel, Health Datapalooza. Washington DC. April 27-28, 2017.
  9. Bradley S, Higgins L. Measuring Value-Based Care with Patient-Reported Outcomes. HIMSS Annual. Orlando, FL. February 19-22, 2017.
  10. Hawkes W, Patil D, Su Z. Analytic Approaches to Handling Missing Data in Observational Studies. FDA ASA Biopharmaceutical Section-Regulatory Industry Statistics. Washington DC. September 28, 2016.
  11. Gliklich R, Leavy M. Identifying Patient-Centered Outcomes for Use in Observational Research: Why and How. Issues panels. Drug Information Association Annual. Philadelphia, PA. June 26-30, 2016.
  12. Patil D, Liu J, Su Z. Comparing Confidence Intervals of Incidence Rates. ISPOR Annual Conference. Washington DC. May 22-25, 2016.

Back to top